UrgoStart® TREATMENT RANGE

nosf-img

The UrgoStart® treatment range of dressings is innovative technology combining Technology Lipido-Colloid (TLC) with Nano-Oligo Saccharide Factor. Dressings in this range offer an optimum healing process.* The TLC-NOSF combination leads to the restoration of wound bed conditions that promote granulation of chronic wounds, in which a metabolic imbalance has led to a continuous degration of the extracellular matrix, and possibly to delayed healing.

TLC-

when the gelling action of the TLC combines with hydrocolloid particles, TLC forms a Lipido-Colloid gel, creating a moist environment that promotes the healing process, so that key cells involved in the repair process (fibroblasts, keratinocytes, macrophages) can exert their action.

NOSF-

provides properties in addition to those of TLC: on contact with wound exudate, NOSF forms a gel which binds preferentially to damaged areas and limits the harmful action of MMPs (Matrix Metalloprotienases)1.

*The recommended treatment duration for UrgoStart® dressings 4-5 weeks or to healing

  1. 1. White, R., Cowan, T., Glover, D. Supporting evidence-based practice: a clinical review of TLC healing matrix (2nd edition). MA Healthcare Ltd, London, 2015.

UrgoStart® Products

UrgoStart® Border

An innovative border foam pad dressing combining a polyurethane foam pad with a ....

UrgoStart® Contact

An innovative, non-adhesive, non-occlusive matrix with TLC-NOSF technology.  It....

UrgoStart® Foam Pad

An innovative dressing combining a polyurethane foam pad with a TLC-NOSF healing....

Page updated on 3 June 2022